GHU Paris Sainte Anne
Paris, 75014, France
Location status: Recruiting
Location contact
Estelle Pruvost-Robieux, MD, PHD
CONTACT
Estelle Pruvost-Robieux, MD, PHD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07544563
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function
Interested in participating?
Request Info18 year and older
All sexes
Observational
Paris, 75014, France
Location status: Recruiting
Estelle Pruvost-Robieux, MD, PHD
CONTACT
Estelle Pruvost-Robieux, MD, PHD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: All along the study (8 years)
Description of the neural networks involved during exposure to sensory stimuli
Time frame: 8 years
Assessment of the Generalized Anxiety Disorder-7 (GAD7) in the exposed patients across the hospitalization :
minimum value 0; maximum 21; higher scores mean a worse outcome
Time frame: 8 years
Assessment of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) in the exposed patients across the hospitalization : minimum value 6; maximum 24; higher scores mean a worse outcome
Time frame: 8 years
Assessment of the QOLIE-31(quality of life in epilepsy) scale among exposed patients
Contact information is provided by the study sponsor or research team.
Centre Hospitalier St Anne
Other
Exploration phénotypique en Contexte de Stimulations Sensorielles en Chambre Acoustique
Acronym: EMO-INTRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04526093
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT05559749
Anxiety, Anxiety Disorders
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06551090
Anxiety, Anxiety Disorders
New York, United States
View Trial DetailsNCT05152992
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial Details